Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of AbbVie's Tavapadon?
Tavapadon is a small molecule commercialized by AbbVie, with a leading Phase III program in Parkinson's Disease. According to Globaldata,...
Risk adjusted net present value: What is the current valuation of Cerevel Therapeutics's Tavapadon?
Tavapadon is a small molecule commercialized by Cerevel Therapeutics, with a leading Phase III program in Parkinson's Disease. According to...
Tavapadon by Cerevel Therapeutics for Parkinson's Disease: Likelihood of Approval
Tavapadon is under clinical development by Cerevel Therapeutics and currently in Phase III for Parkinson's Disease. According to GlobalData, Phase...